9Indexed trials
drug · Product Intelligence
Memantine
Pipeline Intelligence
Memantine: 9 indexed trials, 9 sponsors; 0 linked Orange Book patents and 11 FDA-linked events where matched.
9Sponsors
0Orange Book patent links
11FDA-linked events
Development evidence
NCT00255086Stanford University · alzheimersPHASE3
NCT00476008Florida Atlantic University · alzheimersPHASE4
NCT00505167Hospital Miguel Servet · alzheimersPHASE4
NCT00649220Merz Pharmaceuticals GmbH · alzheimersPHASE4
NCT00986115University of California, Davis · epilepsyNA
NCT02580305Suven Life Sciences Limited · alzheimersPHASE2
NCT03858270Wayne State University · parkinsonsPHASE3
NCT04117178Zealand University Hospital · alzheimersPHASE4
NCT05664464University of Zurich · epilepsyPHASE1, PHASE2
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2021-04-02
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2020-12-11
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2020-08-31
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2020-04-03
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2018-07-11
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2017-07-10
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2015-10-13
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2015-07-31
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2015-04-10
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2012-03-12
FDA_APPROVALMEMANTINE HYDROCHLORIDE · 2010-04-14
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.